捷安高科(300845) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥24,907,487.12, representing a 4.85% increase compared to ¥23,755,588.99 in the same period last year[5] - The net loss attributable to shareholders was ¥6,795,575.60, a 41.61% increase from a loss of ¥4,798,762.19 in the previous year[5] - Net profit for the current period was a loss of ¥6,971,322.51, compared to a loss of ¥4,976,314.16 in the previous period, representing a deterioration of 40.14%[17] - Operating profit for the current period was a loss of ¥6,392,255.69, worsening from a loss of ¥4,278,154.87 in the previous period[17] - Basic and diluted earnings per share for the current period were both -¥0.05, compared to -¥0.04 in the previous period[18] - The company reported a total comprehensive loss of ¥6,971,322.51 for the current period, compared to a loss of ¥4,976,314.16 in the previous period[18] Cash Flow - The net cash flow from operating activities was -¥40,900,972.14, which is a 10.17% decline compared to -¥37,125,462.26 in the prior year[5] - Cash flow from operating activities showed a net outflow of ¥40,900,972.14, compared to a net outflow of ¥37,125,462.26 in the previous period[19] - The net cash flow from investing activities improved by 57.29% to -¥2,753,660.30, attributed to reduced capital expenditures[9] - The company reported a 100% change in financing cash flow, with no cash flow from financing activities compared to -¥20,319,665.44 in the previous year, due to share repurchase activities last year[9] Assets and Liabilities - The total assets decreased by 5.90% to ¥997,981,188.59 from ¥1,060,578,293.24 at the end of the previous year[5] - Total current assets decreased from 704,963,296.95 CNY to 645,785,789.29 CNY, a reduction of approximately 8.5%[13] - Total liabilities decreased from 222,009,126.03 CNY to 164,257,754.37 CNY, a reduction of approximately 26%[14] - The company's cash and cash equivalents decreased from 282,004,542.07 CNY to 236,843,498.38 CNY, a decline of about 16.0%[13] - The total equity attributable to the parent company decreased from 835,564,515.69 CNY to 830,894,529.61 CNY, a slight decline of about 0.8%[15] - The company has a total of 352,195,399.30 CNY in non-current assets, slightly down from 355,614,996.29 CNY[14] - The company’s total liabilities and equity sum to 997,981,188.59 CNY, matching the total assets[15] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,351[11] - The top two shareholders, Zheng Leguan and Zhang Anquan, hold 14.90% and 14.27% of shares respectively, totaling 42,556,243 shares[11] Other Income and Expenses - Other income decreased by 46.96% to ¥1,887,588.55, mainly due to incomplete government subsidy approvals[9] - Research and development expenses increased to ¥8,676,916.90, up 14.87% from ¥7,550,766.20 in the previous period[16] - Other income decreased to ¥1,887,588.55 from ¥3,558,898.84 in the previous period, a decline of 46.96%[16] Accounts Receivable - The company reported a significant increase in accounts receivable, which rose by 94.14% to ¥10,329,844.55 due to outstanding commercial acceptance bills[8] - The company reported accounts receivable of 186,769,364.02 CNY, down from 219,334,941.76 CNY, a decrease of approximately 16.6%[13] - The company experienced a 381.32% increase in receivables financing, reaching ¥9,610,495.85, primarily due to outstanding bank acceptance bills[8]